Cars100, I also was a long-time subscriber to Zacks SCR and I have owned CTSO since 2013. My warning is not about CTSO but about Zacks. Can analysts be brutally honest about a stock -- outlining risks of all kind -- when they are being paid up to $50,000 per year to cover that stock?! Just one example: Zacks seldom covers liquidity or the near-term needs for financing of small biotech companies. It's no accident that they don't list current cash balances and seldom include that in their analysis.
So just keep in mind where their bread is buttered. It's not the fees that their investor subscribers like you pay (and me for many years too). It's the tens of thousands of dollars that each company pays them. You seldom if ever see a negative report or a sell recommendation, even when the news is bad. Their coverage is almost always bright future, tons of potential, etc., etc. And then they drop coverage without notifying their subscribers when the companies stop paying them for whatever reason. A year or more can go by before you realize that happened (and the value of that stock is near worthless).
Caveat Emptor.
News 
Market Data 
Discover 
